Nootropics Factory Supply Idra21 Purity 99% Powder CAS 22503-72-6

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >98%
• Model NO.: IDRA21
• Product Name: Idra21
• CAS No.: 22503-72-6
• Molecular Formula: C8h9cln2o2s
• Molecular Weight: 232.69
• Melting Point: 209 °c(Solv: Acetic Acid
• Boiling Point: 405.1±55.0 °c(Predicted)
• Preservation Conditions: Store at Rt
• Transport Package: Foil Bag
• Specification: 1kg /bag
• Trademark: SENWAYER
• Origin: China
• HS Code: 2933790099
• Production Capacity: 500kg/Month

Product Description

Nootropics Factory Supply IDRA21 Purity 99% Powder CAS 22503-72-6

Product name	IDRA21
CAS number	22503-72-6
Molecular formula	C8H9ClN2O2S
Molecular weight	232.69
Melting point	209 °C(Solv: acetic acid
Boiling point	405.1±55.0 °C(Predicted)
Density	1.394±0.06 g/cm3(Predicted)

Appearance	White Powder
Purity	99.0%
Function	1.Idra-21 can Increases in cognition 2.Idra-21 can Increased Task Accuracy 3.Idra-21 can Increases in Short Term Memory 4.Idra-21 can Potential Therapeutic Effects On Depression 5.Idra-21 can Neuroprotection 6.Idra-21 can Potential Therapeutic Effects On Schizophrenia
Discribe	IDRA-21 is a positive allosteric modulator (PAM) of the AMPA receptor and a benzothiadiazine derivative. It is a chiral molecule, with (+)-IDRA-21 being the active form. IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by  scopolamine, and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.

  IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by orscopolamine,and produces sustained effects lasting for up to 48 hours after a single dose.The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain. IDRA-21 does not produce neurotoxicity under normal conditions,although it may worsen neuronal damage following global ischemia after stroke or seizures.